BTBD9-DNAH8 Fusion FISH Probe
The BTBD9-DNAH8 Fusion FISH Probe is used to confirm a fusion of the BTBD9 and DNAH8 genes. The fusion of the BTBD9 and DNAH8 genes has been associated with Skin Cutaneous Melanoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| BTBD9-DNAH8-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| BTBD9-DNAH8-20-RERE | 20 (40 μL) | 200 μL |
|
|
| BTBD9-DNAH8-20-REOR | 20 (40 μL) | 200 μL |
|
|
| BTBD9-DNAH8-20-REGO | 20 (40 μL) | 200 μL |
|
|
| BTBD9-DNAH8-20-REGR | 20 (40 μL) | 200 μL |
|
|
| BTBD9-DNAH8-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| BTBD9-DNAH8-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| BTBD9-DNAH8-20-OROR | 20 (40 μL) | 200 μL |
|
|
| BTBD9-DNAH8-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| BTBD9-DNAH8-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| BTBD9-DNAH8-20-GORE | 20 (40 μL) | 200 μL |
|
|
| BTBD9-DNAH8-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| BTBD9-DNAH8-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| BTBD9-DNAH8-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| BTBD9-DNAH8-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| BTBD9-DNAH8-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| BTBD9-DNAH8-20-GROR | 20 (40 μL) | 200 μL |
|
|
| BTBD9-DNAH8-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| BTBD9-DNAH8-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| BTBD9-DNAH8-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| BTBD9-DNAH8-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| BTBD9-DNAH8-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| BTBD9-DNAH8-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| BTBD9-DNAH8-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| BTBD9-DNAH8-20-AQAQ | 20 (40 μL) | 200 μL |
|
DNAH8 Gene Summary
The protein encoded by this gene is a heavy chain of an axonemal dynein involved in sperm and respiratory cilia motility. Axonemal dyneins generate force through hydrolysis of ATP and binding to microtubules. [provided by RefSeq, Jan 2012]
Gene Name: Dynein Axonemal Heavy Chain 8
Chromosome: CHR6: 38683116 -38998574
Locus: 6p21.2
BTBD9 Gene Summary
This locus encodes a BTB/POZ domain-containing protein. This domain is known to be involved in protein-protein interactions. Polymorphisms at this locus have been reported to be associated with susceptibility to Restless Legs Syndrome and may also be associated with Tourette Syndrome. Alternatively spliced transcript variants have been described. [provided by RefSeq, Aug 2011]
Gene Name: BTB Domain Containing 9
Chromosome: CHR6: 38136226 -38607924
Locus: 6p21.2
Gene Diseases
The BTBD9 DNAH8 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Skin Cutaneous Melanoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|